Researchers have revealed crucial insights into how the Warburg effect causes the dedifferentiation of cancer cells through epigenetic reprogramming. This discovery potentially opens up new avenues for cancer treatments that ...
May 3, 2024
0
0
During hepatic surgery or liver transplantation, the liver is vulnerable to ischemia-reperfusion injury (IRI), especially when vessels are compressed to control bleeding or during periods of ischemia. The hallmark of IRI ...
Apr 30, 2024
0
0
A team of researchers at Johannes Gutenberg University Mainz (JGU) has identified a mechanism that causes mitochondrial dysfunction in Alzheimer's patients resulting in a reduction of the supply of energy to the brain.
Apr 25, 2024
0
47
One in every 10 individuals above the age of 65 develops an age-related neurological disorder like Alzheimer's or Parkinson's, yet treatment options remain sparse for this population. Scientists have begun exploring whether ...
Apr 17, 2024
1
140
Autism spectrum disorder (ASD) is a group of neurodevelopmental disorders characterized by early abnormal social communication and restricted repetitive behaviors and interests. The prevalence of ASD continues to rise and ...
Apr 15, 2024
0
1
The lab of Yongchao C. Ma, Ph.D., at Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago has discovered a fundamental biological mechanism that could lead to new treatments ...
Apr 5, 2024
0
11
A new research paper titled "Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging" has been published in Aging.
Apr 3, 2024
0
0
While cancer remains one of the leading global causes of death, advancements in cancer therapies have significantly improved its manageability and potential for cure. Among these revolutionary cancer treatments are chimeric ...
Mar 26, 2024
0
0
A new meta-analysis published in OMICS: A Journal of Integrative Biology helps shed light on how changes in mitochondria-related gene expression may cause the cardiotoxicity associated with the cancer therapy trastuzumab.
Mar 18, 2024
0
0
A new research paper titled "GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells" has been published in Oncotarget.
Feb 27, 2024
0
1
